Junjun Wang

710 total citations
34 papers, 530 citations indexed

About

Junjun Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junjun Wang has authored 34 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Junjun Wang's work include Cancer-related molecular mechanisms research (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and RNA modifications and cancer (5 papers). Junjun Wang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and RNA modifications and cancer (5 papers). Junjun Wang collaborates with scholars based in China and United States. Junjun Wang's co-authors include Chang Xia, Wei‐Chiang Shen, Yumin Wang, Lijuan Hu, Fan Zhang, Liangrong Shi, Yibei Zhu, Nianhua Ding, Yi Zhang and Jie Chen and has published in prestigious journals such as Nature Communications, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Immunology.

In The Last Decade

Junjun Wang

32 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjun Wang China 10 213 142 115 103 79 34 530
Wenjiao Zeng China 13 228 1.1× 106 0.7× 78 0.7× 94 0.9× 53 0.7× 26 606
Sifeng Tao China 11 371 1.7× 92 0.6× 87 0.8× 210 2.0× 80 1.0× 16 645
Jingwen Deng China 12 190 0.9× 111 0.8× 109 0.9× 95 0.9× 101 1.3× 26 505
Minyue Zhang China 10 190 0.9× 73 0.5× 45 0.4× 33 0.3× 34 0.4× 25 526
Yizhou Zheng China 12 255 1.2× 115 0.8× 62 0.5× 66 0.6× 21 0.3× 28 504
Jiafeng Gao China 15 250 1.2× 79 0.6× 70 0.6× 101 1.0× 62 0.8× 22 472
Ke Zhu China 17 214 1.0× 116 0.8× 136 1.2× 62 0.6× 69 0.9× 33 594

Countries citing papers authored by Junjun Wang

Since Specialization
Citations

This map shows the geographic impact of Junjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjun Wang more than expected).

Fields of papers citing papers by Junjun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjun Wang. The network helps show where Junjun Wang may publish in the future.

Co-authorship network of co-authors of Junjun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junjun Wang. A scholar is included among the top collaborators of Junjun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjun Wang. Junjun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Junjun, Yue Lou, Shicheng Wang, et al.. (2024). IFNγ at the early stage induced after cryo-thermal therapy maintains CD4+ Th1-prone differentiation, leading to long-term antitumor immunity. Frontiers in Immunology. 15. 1345046–1345046. 1 indexed citations
2.
Wang, Shicheng, Junjun Wang, Yue Lou, et al.. (2024). Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy. Frontiers in Immunology. 15. 1445513–1445513. 1 indexed citations
4.
Wang, Shicheng, et al.. (2024). Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy. Cancer Immunology Immunotherapy. 74(1). 21–21. 1 indexed citations
5.
Chen, Shuhui, et al.. (2024). Low Expression MCEMP1 Promotes Lung Adenocarcinoma Progression and its Clinical Value. Current Cancer Drug Targets. 25(3). 281–293.
7.
Yang, Yan, Junjun Wang, Hanqi Yang, et al.. (2023). Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer. Frontiers in Oncology. 13. 1185240–1185240.
8.
Jiang, Feng, Qiang Shen, Fan Zhang, et al.. (2022). ADH1C Facilitates Cisplatin Resistance of Lung Adenocarcinoma Cells. DNA and Cell Biology. 41(6). 631–640. 10 indexed citations
9.
Xiao, Zhu, Ying Zhou, Wansi Zhong, et al.. (2022). Higher Functional Connectivity of Ventral Attention and Visual Network to Maintain Cognitive Performance in White Matter Hyperintensity. Aging and Disease. 14(4). 0–0. 7 indexed citations
10.
Jiang, Feng, Xiaolu Huang, Fan Zhang, et al.. (2022). Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer. DNA and Cell Biology. 41(3). 305–318. 6 indexed citations
11.
Shi, Wenjing, Lijuan Hu, Junjun Wang, et al.. (2021). Low‐level EFCAB1 promoted progress by upregulated DNMT3B and could be as a potential biomarker in lung adenocarcinoma. Journal of Clinical Laboratory Analysis. 36(1). e24166–e24166. 2 indexed citations
12.
Chen, Jie, Feng Jiang, Lijuan Hu, et al.. (2020). lncRNA RP11‐838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma. BioMed Research International. 2020(1). 2806042–2806042. 4 indexed citations
13.
Shi, Liangrong, Junjun Wang, Nianhua Ding, et al.. (2019). Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nature Communications. 10(1). 5421–5421. 203 indexed citations
14.
Hu, Lijuan, Jian Chen, Fan Zhang, et al.. (2017). Aberrant Long Noncoding RNAs Expression Profiles Affect Cisplatin Resistance in Lung Adenocarcinoma. BioMed Research International. 2017. 1–14. 13 indexed citations
15.
Chen, Jian, Lijuan Hu, Fan Zhang, et al.. (2017). Downregulation of carbonic anhydrase IV contributes to promotion of cell proliferation and is associated with poor prognosis in non-small cell lung cancer. Oncology Letters. 14(4). 5046–5050. 5 indexed citations
16.
Chen, Jingya, et al.. (2016). In vivo effect of borneol on rat hepatic CYP2B expression and activity. Chemico-Biological Interactions. 261. 96–102. 14 indexed citations
17.
Wang, Junjun, et al.. (2015). Retinal artery lesions and long-term outcome in Chinese patients with acute coronary syndrome. Eye. 29(5). 643–648. 3 indexed citations
18.
Wang, Junjun, et al.. (2014). The Effect of Streptozotocin and Alloxan on the mRNA Expression of Rat Hepatic Transporters In Vivo. AAPS PharmSciTech. 16(4). 767–770. 5 indexed citations
19.
Wang, Junjun, et al.. (2010). Effects of ginsenoside Rb1 on cell proliferation,differentiation and OPG/RANKL mRNA expression of rat osteoblast cultured in vitro. Zhonghua zhongyiyao zazhi. 25(1). 134–136. 4 indexed citations
20.
Xia, Chang, Junjun Wang, & Wei‐Chiang Shen. (2000). Hypoglycemic Effect of Insulin-Transferrin Conjugate in Streptozotocin-Induced Diabetic Rats. Journal of Pharmacology and Experimental Therapeutics. 295(2). 594–600. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026